Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnWeb3SquareMore
Trade
Spot
Buy and sell crypto with ease
Margin
Amplify your capital and maximize fund efficiency
Onchain
Going Onchain, without going Onchain!
Convert
Zero fees, no slippage
Explore
Launchhub
Gain the edge early and start winning
Copy
Copy elite trader with one click
Bots
Simple, fast, and reliable AI trading bot
Trade
USDT-M Futures
Futures settled in USDT
USDC-M Futures
Futures settled in USDC
Coin-M Futures
Futures settled in cryptocurrencies
Explore
Futures guide
A beginner-to-advanced journey in futures trading
Futures promotions
Generous rewards await
Overview
A variety of products to grow your assets
Simple Earn
Deposit and withdraw anytime to earn flexible returns with zero risk
On-chain Earn
Earn profits daily without risking principal
Structured Earn
Robust financial innovation to navigate market swings
VIP and Wealth Management
Premium services for smart wealth management
Loans
Flexible borrowing with high fund security
Companies Begin Racing to Buy Bitcoin (BTC) – Nasdaq-Listed Company To Purchase $1 Billion Worth of BTC

Companies Begin Racing to Buy Bitcoin (BTC) – Nasdaq-Listed Company To Purchase $1 Billion Worth of BTC

CryptoNewsNetCryptoNewsNet2025/05/16 17:55
By:en.bitcoinsistemi.com

Nasdaq-listed Basel Medical Group (BMGL) announced that it has begun exclusive talks to purchase $1 billion worth of Bitcoin (BTC).

The company plans to make this large-scale BTC purchase through a stock swap arrangement with institutional investors and crypto-influential HNWIs. The transaction is expected to be completed within the current quarter.

According to a press release by BMGL, this strategic move aims to support the company’s expansion plans in Asia’s high-growth healthcare market by strengthening its balance sheet. The company stated that the Bitcoin purchase will significantly diversify its treasury as it continues to focus on medical services.

“This $1 billion financial transformation will provide an unprecedented boost to our capacity to execute our growth strategy in Asia,” said Dr. Darren Chhoa, CEO of Basel Medical Group. “Our expanded balance sheet will enable us to respond quickly to strategic opportunities.”

According to the statements in the published press release, with the planned capital infusion, the company:

  • It will have one of the strongest balance sheets among Asian healthcare providers,
  • Gain significant flexibility in acquisitions and mergers,
  • Create a diversified asset base that is resilient to market fluctuations,
  • It will become a medical group with a strong capital structure in emerging Asian markets.

*This is not investment advice.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Locked for new tokens.
APR up to 10%. Always on, always get airdrop.
Lock now!